Samuel Washington, MD, MAS

Title(s)Assistant Professor, Urology
SchoolSchool of Medicine
Address550 16th Street, #001
San Francisco CA 94158
Phone415-353-7171
ORCID ORCID Icon0000-0002-2467-6115 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Davis, Davis, CABS06/2007Genetics; Latin minor
    University of California, San Francisco, San Francisco, CA06/2011Pathways to Careers in Clinical and Translational Research Yearlong Fellowship
    University of California, San Francisco, San Francisco, CAMD06/2012Medicine
    University of California, San Francisco, San Francisco, CA06/2018Urology surgical Residency
    University of California, San Francisco, San Francisco, CAUrologic Oncology Fellowship
    University of California, San Francisco, San Francisco, CAMAS06/2019Advanced Training in Clinical & Translational Research Program
    Collapse Awards and Honors
    Miley B. Wesson Resident Essay Contest, Third Place; Western Section American Urological Association2016Incidence of Prostate Cancer within Skeletal Muscle at the Prostate Apex in Men Undergoing Radical P
    43rd Annual Northern California Residents’ Research Seminar, First Place for Clinical Science Sectio2017Interaction between Histologic Subtype and Ethnicity on Bladder Cancer Outcome
    Bladder Cancer Advocacy Network2019John Quale Travel Fellowship
    Region 5 Geographic Management of Cancer Health Disparities Program201912th American Association of Cancer Researchers Conference on The Science of Cancer Health Dispariti
    OptumLabs – University of California Partnership2019OptumLabs Health Data for Action: Leveraging Health Data for Actionable Insights Data Access Award
    University of California, San Francisco2021Goldberg-Benioff Endowed Professorship in Cancer Biology
    ConcertAI2021Engaging Research to Achieve Cancer Care Equity Research Award
    San Francisco VA Health Care System2021Grunfeld Scholars
    University of California, San Francisco2021John A. Watson Faculty Scholar

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    An Atlas of Human Prostate AcrossAncestries to develop a comprehensive atlas of the human pros-tate at single-cell resolution with a community engagement plan to maximize impact for the public and clinical and scientific communities
    Chan Zuckerberg Initiative DAF P0559192Dec 2, 2021 - Nov 30, 2024
    Role: Co-Principal Investigator
    Drivers of racial disparities in management of advanced prostate cancer: examining local and geo-graphic variations in evaluation and treatment.
    ConcertAI Dec 1, 2021 - Nov 30, 2022
    Role: Principal Investigator
    Impact of socioeconomic status on overutilization of healthcare expenditure in patients with bladder cancer
    OptumLabs 20183Oct 1, 2019 - Oct 1, 2020
    Role: Co-Investigator
    The Differential Impact of Race on Oncologic Outcomes in Elderly Patients with Bladder Cancer: A Population-based Study
    NIA RCMAR/UCSF Center for Aging in Diverse Communities Scholars Program 132016CJul 1, 2018 - Jun 30, 2019
    Role: Co-Principal Investigator
    The Interventions to Reduce Resident Exhaustion and Depersonalization
    UCSF Academy of Medical EducatorsUCSF 1000112Jul 1, 2017 - Jun 30, 2018
    Role: Co-Principal Investigator
    Biomechanical computed tomography facilitates the diagnosis of osteoporosis and fracture prediction in patients with high risk prostate cancer
    US Department of Defense W81XWH-21-PCRP-DSA
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Faculty Mentoring

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-Based vs Physical Exam-Based Staging. J Urol. 2023 Apr 26; 101097JU0000000000003486. Chang K, Greenberg SA, Cowan JE, Parker R, Shee K, Washington SL, Nguyen HG, Shinohara K, Carrol PR, Cooperberg MR. PMID: 37099018.
      View in: PubMed   Mentions:    Fields:    
    2. PSA density does not improve predictive accuracy of the UCSF-CAPRA score. Prostate. 2023 Apr 20. Parker R, Bell A, Chang K, Greenberg S, Washington SL, Cowan JE, Carroll PR, Cooperberg MR. PMID: 37078628.
      View in: PubMed   Mentions:    Fields:    
    3. Prostate cancer disparities among American Indians and Alaskan Natives in the United States. J Natl Cancer Inst. 2023 Apr 11; 115(4):413-420. Chu CE, Leapman MS, Zhao S, Cowan JE, Washington SL, Cooperberg MR. PMID: 36629492; PMCID: PMC10086629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. World J Mens Health. 2023 Mar 15. Han JH, Herlemann A, Washington SL, Lonergan PE, Carroll PR, Cooperberg MR, Jeong CW. PMID: 37118954.
      View in: PubMed   Mentions:
    5. Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort. Eur Urol. 2023 Mar 02. Shee K, Cowan JE, Balakrishnan A, Escobar D, Chang K, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 36870794.
      View in: PubMed   Mentions:    Fields:    
    6. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Netw. 2023 03; 21(3):236-246. Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. PMID: 36898362.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Mar 01. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
      View in: PubMed   Mentions:    Fields:    
    8. Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system. Cancer Med. 2023 03; 12(6):6945-6955. Caram MEV, Kumbier K, Burns J, Sparks JB, Tsao PA, Stensland KD, Washington SL, Hollenbeck BK, Shahinian V, Skolarus TA. PMID: 36790037; PMCID: PMC10067072.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The natural history of a delayed detectable PSA after radical prostatectomy. Prostate Cancer Prostatic Dis. 2023 Feb 10. Szymaniak JA, Washington SL, Cowan JE, Cooperberg MR, Lonergan PE, Nguyen HG, Meng MV, Carroll PR. PMID: 36765111.
      View in: PubMed   Mentions:    Fields:    
    10. Urologists in Advocacy: The Key to Addressing Disparities in Prostate Cancer. J Urol. 2022 Nov 17; 101097JU0000000000003000. Pittman A, Moses KA, Washington SL. PMID: 36394976.
      View in: PubMed   Mentions:    Fields:    
    11. Someone Like Me: An Examination of the Importance of Race-Concordant Mentorship in Urology. Urology. 2022 Oct 20. Penaloza NG, E Zaila Ardines K, Does S, Washington SL, Tandel MD, Braddock CH, Downs TM, Saigal C, Ghanney Simons EC. PMID: 36272563.
      View in: PubMed   Mentions: 1     Fields:    
    12. Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. J Urol. 2022 Sep 06; 101097JU0000000000002956. Shee K, Washington SL, Cowan JE, de la Calle CM, Baskin AS, Chappidi MR, Escobar D, Nguyen HG, Cooperberg MR, Carroll PR. PMID: 36067374.
      View in: PubMed   Mentions: 1     Fields:    
    13. We Must Change Our Approach to Racial Disparities in Prostate Cancer. Eur Urol. 2022 10; 82(4):352-353. Washington SL. PMID: 35934600.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Racial and Ethnic Differences in Medical Student Timing and Perceived Quality of Exposure to Urology. Urology. 2022 10; 168:50-58. Ghanney Simons EC, Ardines KEZ, Penaloza NG, Does S, Washington SL, Tandel MD, Braddock CH, Downs TM, Saigal C. PMID: 35718136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer. JAMA Oncol. 2022 05 01; 8(5):687-696. Leapman MS, Dinan M, Pasha S, Long J, Washington SL, Ma X, Gross CP. PMID: 35238879; PMCID: PMC8895315.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. EDITORIAL COMMENT. Urology. 2022 04; 162:26. Washington SL. PMID: 35469609.
      View in: PubMed   Mentions:    Fields:    
    17. The effect of preoperative membranous urethral length on likelihood of postoperative urinary incontinence after robot-assisted radical prostatectomy. Prostate Cancer Prostatic Dis. 2022 02; 25(2):344-350. Greenberg SA, Cowan JE, Lonergan PE, Washington SL, Nguyen HG, Zagoria RJ, Carroll PR. PMID: 35352026.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    18. The Natural History of Untreated Biopsy Grade Group Progression and Delayed Definitive Treatment for Men on Active Surveillance for Early-Stage Prostate Cancer. J Urol. 2022 05; 207(5):1001-1009. Chappidi MR, Bell A, Cowan JE, Greenberg SA, Lonergan PE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 34981949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital. J Health Care Poor Underserved. 2022; 33(3):1569-1582. Dong A, Nabavizadeh R, Jiang JF, Washington SL, Master VA. PMID: 36245181.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate Cancer. J Urol. 2022 03; 207(3):496-497. Washington SL, Gore JL, Nyame YA. PMID: 34967664.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer. J Urol. 2022 04; 207(4):832-840. Lonergan PE, Washington SL, Cowan JE, Zhao S, Broering JM, Cooperberg MR, Carroll PR. PMID: 34854749.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study. J Nucl Med. 2022 01; 63(1):76-80. Ferdinandus J, Fendler WP, Farolfi A, Washington S, Mohamad O, Pampaloni MH, Scott PJH, Rodnick M, Viglianti BL, Eiber M, Herrmann K, Czernin J, Armstrong WR, Calais J, Hope TA, Piert M. PMID: 34620731; PMCID: PMC8717195.
      View in: PubMed   Mentions: 5     Fields:    
    23. Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database. Prostate Cancer Prostatic Dis. 2022 Apr; 25(4):690-693. Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 34508180; PMCID: PMC9705238.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Formal Mentorship as an Opportunity to Expand the Urology Pipeline: Under Represented Trainees Entering Residency (UReTER) Program Evaluation 2020-2021. Urology. 2022 04; 162:108-113. Zheng MY, Overland M, Escobar D, Fakunle M, Li Y, Chu C, Balakrishnan A, Shee K, Washington S, Hampson L. PMID: 34506807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Trends in the Racial and Ethnic Diversity in the US Urology Workforce. Urology. 2022 04; 162:9-19. Simons ECG, Arevalo A, Washington SL, Does S, Kwan L, Nguyen AV, Downs TM, Braddock CH, Saigal C. PMID: 34469768.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. A Cross-Sectional Analysis of Barriers Associated With Non-Attendance at a Urology Telehealth Clinic in a Safety-Net Hospital. Urology. 2022 04; 162:57-62. Bell A, Lonergan PE, Escobar D, Fakunle M, Chu CE, Berdy S, Palmer NR, Breyer BN, Washington SL. PMID: 34461145.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    27. The state of our understanding of prostate cancer in sub-Saharan Africa. Cancer. 2021 11 15; 127(22):4131-4132. Greenberg SA, Washington SL. PMID: 34328212.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Natural history of an immediately detectable PSA following radical prostatectomy in a contemporary cohort. Prostate. 2021 09; 81(13):1009-1017. Lonergan PE, Cowan JE, Washington SL, Greenberg SA, Nguyen HG, Carroll PR. PMID: 34288004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Residual Benign Prostate Glandular Tissue after Radical Prostatectomy is Not Associated with the Development of Detectable Postoperative Serum Prostate Specific Antigen. J Urol. 2021 09; 206(3):706-714. Greenberg SA, Washington SL, Lonergan PE, Cowan JE, Baskin AS, Nguyen HG, Odisho AY, Simko JP, Carroll PR. PMID: 33905262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Editorial Commentary. Urol Pract. 2021 Jul; 8(4):522. Washington SL, Parker R. PMID: 37145486.
      View in: PubMed   Mentions:
    31. Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality. Curr Oncol Rep. 2021 03 10; 23(3):37. Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA. PMID: 33689041; PMCID: PMC7946660.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansPHPublic Health
    32. EDITORIAL COMMENT. Urology. 2021 02; 148:209-210. Washington SL, Nyame YA. PMID: 33549216.
      View in: PubMed   Mentions:    Fields:    
    33. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2022 10; 5(5):537-543. Chu CE, Cowan JE, Lonergan PE, Washington SL, Fasulo V, de la Calle CM, Shinohara K, Westphalen AC, Carroll PR. PMID: 33483265.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Supporting Black voices in urology. Nat Rev Urol. 2021 01; 18(1):7-17. Downs TM, Enemchukwu E, Lee CT, Moses KA, Nyame YA, Powell IJ, Vince R, Williams H, Wilson S, Washington SL. PMID: 33318668; PMCID: PMC7734897.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173. Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. PMID: 33278460.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    36. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. JAMA Netw Open. 2020 12 01; 3(12):e2031349. Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 33369661; PMCID: PMC7770559.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    37. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide? J Urol. 2021 Jan; 205(1):109-114. Chu CE, Cowan JE, Fasulo V, Washington SL, de la Calle C, Shoemaker J, Carroll PR. PMID: 33198555.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Health literacy and shared decision making in prostate cancer screening: Equality versus equity. Cancer. 2021 01 15; 127(2):181-183. Washington SL, Master VA. PMID: 33164210.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1222-1228. Maggi M, Cowan JE, Fasulo V, Washington SL, Lonergan PE, Sciarra A, Nguyen HG, Carroll PR. PMID: 33157570.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    40. Monitoring Prostate Cancer Incidence Trends: Value of Multiple Imputation and Delay Adjustment to Discern Disparities in Stage-specific Trends. Eur Urol. 2021 01; 79(1):42-43. Gomez SL, Washington SL, Cheng I, Huang FW, Cooperberg MR. PMID: 33153814.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Influence of pelvic lymph node dissection and node-positive disease on biochemical recurrence, secondary treatment, and survival after radical prostatectomy in men with prostate cancer. Prostate. 2021 02; 81(2):102-108. Washington SL, Cowan JE, Herlemann A, Zuniga KB, Masic S, Nguyen HG, Carroll PR. PMID: 33075151.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Eur Urol Oncol. 2022 02; 5(1):61-69. Fasulo V, Cowan JE, Maggi M, Washington SL, Nguyen HG, Shinohara K, Lazzeri M, Casale P, Carroll PR. PMID: 33069628.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    43. Reply by Authors. J Urol. 2020 12; 204(6):1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32969756.
      View in: PubMed   Mentions:    Fields:    
    44. Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer. Cancer Med. 2020 11; 9(22):8310-8317. Washington SL, Gregorich SE, Meng MV, Suskind AM, Porten SP. PMID: 32869516; PMCID: PMC7666728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? Eur Urol Focus. 2021 Nov; 7(6):1268-1273. Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR. PMID: 32868222.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    46. Disparities in fertility knowledge among women from low and high resource settings presenting for fertility care in two United States metropolitan centers. Fertil Res Pract. 2020; 6:15. Hoffman JR, Delaney MA, Valdes CT, Herrera D, Washington SL, Aghajanova L, Smith JF, Herndon CN. PMID: 32821417; PMCID: PMC7429753.
      View in: PubMed   Mentions: 3  
    47. Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database. World J Urol. 2021 Jun; 39(6):1911-1916. de la Calle CM, Washington SL, Lonergan PE, Meng MV, Porten SP. PMID: 32737581.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    48. Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database. BMC Urol. 2020 07 17; 20(1):103. Zuniga KB, Washington SL, Porten SP, Meng MV. PMID: 32680507; PMCID: PMC7368670.
      View in: PubMed   Mentions:    Fields:    
    49. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. Eur Urol. 2020 10; 78(4):515-517. Chu CE, Lonergan PE, Washington SL, Cowan JE, Shinohara K, Westphalen AC, Carroll PR, Cooperberg MR. PMID: 32631744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Risk Factors for Biopsy Reclassification over Time in Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2020 12; 204(6):1216-1221. Lonergan PE, Washington SL, Cowan JE, Zhao S, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 32519915.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    51. A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database. BMC Urol. 2020 Apr 17; 20(1):40. Zuniga KB, Washington SL, Porten SP, Meng MV. PMID: 32303266; PMCID: PMC7164279.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations. Eur Urol. 2020 09; 78(3):335-344. Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR. PMID: 31980309.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    53. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort. AJR Am J Roentgenol. 2020 03; 214(3):574-578. Washington SL, Baskin AS, Ameli N, Nguyen HG, Westphalen AC, Shinohara K, Carroll PR. PMID: 31913068.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Active surveillance for intermediate-risk prostate cancer: yes, but for whom? Curr Opin Urol. 2019 11; 29(6):605-611. Overland MR, Washington SL, Carroll PR, Cooperberg MR, Herlemann A. PMID: 31436567.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. What is the Impact of Racial Disparities on Diagnosis and Receipt of Appropriate Mental Health Care Among Urology Patients? Eur Urol Focus. 2020 11 15; 6(6):1155-1157. Washington SL, Nyame YA, Moses KA. PMID: 31542408; PMCID: PMC8544018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    56. Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance for Early Stage Prostate Cancer. J Urol. 2019 10; 202(4):696-701. Cedars BE, Washington SL, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR. PMID: 30958742.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Perspectives From Authors and Editors in the Biomedical Disciplines on Predatory Journals: Survey Study. J Med Internet Res. 2019 08 30; 21(8):e13769. Cohen AJ, Patino G, Kamal P, Ndoye M, Tresh A, Mena J, Butler C, Washington S, Breyer BN. PMID: 31471960; PMCID: PMC6743260.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    58. The Impact of Stone Multiplicity on Surgical Decisions for Patients with Large Stone Burden: Results from ReSKU. J Endourol. 2019 09; 33(9):742-749. Zetumer S, Wiener S, Bayne DB, Armas-Phan M, Washington SL, Tzou DT, Stoller M, Chi T. PMID: 31044624; PMCID: PMC6748398.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research. JCO Clin Cancer Inform. 2019 07; 3:1-8. Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL, Herlemann A, Carroll PR, Cooperberg MR. PMID: 31314550; PMCID: PMC6874052.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    60. Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1339-1344. Washington SL, Neuhaus J, Meng MV, Porten SP. PMID: 31092404; PMCID: PMC6679737.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    61. Altruistic donation to improve survey responses: a global randomized trial. BMC Res Notes. 2019 Feb 28; 12(1):113. Cohen AJ, Washington S, Butler C, Kamal P, Patino G, Tresh A, Mena J, Ndoye M, Breyer BN. PMID: 30819217; PMCID: PMC6396474.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. The Association Between Race and Frailty in Older Adults Presenting to a Nononcologic Urology Practice. Urology. 2019 05; 127:19-23. Washington SL, Porten SP, Quanstrom K, Jin C, Bridge M, Finlayson E, Walter LC, Suskind AM. PMID: 30822479; PMCID: PMC6495603.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer. Clin Genitourin Cancer. 2019 06; 17(3):e461-e471. Balakrishnan AS, Washington SL, Meng MV, Porten SP. PMID: 30799130.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    64. Health Care Delivery for Metastatic Hormone-sensitive Prostate Cancer Across the Globe. Eur Urol Focus. 2019 03; 5(2):155-158. Herlemann A, Washington SL, Cooperberg MR. PMID: 30587443.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Racial distribution of urology workforce in United States in comparison to general population. Transl Androl Urol. 2018 Aug; 7(4):526-534. Washington SL, Baradaran N, Gaither TW, Awad MA, Murphy GP, Downs TM, Breyer BN. PMID: 30211043; PMCID: PMC6127557.
      View in: PubMed   Mentions: 2  
    66. Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer. Eur Urol Oncol. 2018 10; 1(5):386-394. Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR. PMID: 31158077.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    67. Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier. Urol Clin North Am. 2017 Nov; 44(4):547-555. Herlemann A, Washington SL, Eapen RS, Cooperberg MR. PMID: 29107271.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. Web-Based Physician Ratings for California Physicians on Probation. J Med Internet Res. 2017 08 22; 19(8):e254. Murphy GP, Awad MA, Osterberg EC, Gaither TW, Chumnarnsongkhroh T, Washington SL, Breyer BN. PMID: 28830852; PMCID: PMC5585591.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    69. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging. Curr Opin Urol. 2017 May; 27(3):205-209. Eapen RS, Herlemann A, Washington SL, Cooperberg MR. PMID: 28221220.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansPHPublic Health
    70. Management of intermediate-risk prostate cancer with active surveillance: never or sometimes? Curr Opin Urol. 2017 May; 27(3):231-237. Masic S, Washington SL, Carroll PR. PMID: 28234748.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Ultrasound-Guided Renal Access and Tract Dilation. Videourology (New Rochelle). 2017; 31(1). Usawachintachit M, Tzou DT, Washington SL, Hu W, Li J, Chi T. PMID: 32292638; PMCID: PMC6964241.
      View in: PubMed   Mentions:
    72. Cystoscopic Evaluation of Bladder Leiomyoma. Urology. 2017 Aug; 106:e1-e2. Washington SL, Eslami A, Tzou DT. PMID: 28161381.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Acute Bladder Necrosis after Pelvic Arterial Embolization for Pelvic Trauma: Lessons Learned from Two Cases of Immediate Postembolization Bladder Necrosis. Case Rep Urol. 2016; 2016:7594192. Washington S, Osterberg EC, Elliott SP, Hittelman AB, Breyer BN. PMID: 27656309; PMCID: PMC5021480.
      View in: PubMed   Mentions: 1  
    74. Current Use of Imaging after Primary Treatment of Prostate Cancer. J Urol. 2015 Jul; 194(1):98-104. Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR. PMID: 25640648.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort. Urology. 2014 Jan; 83(1):33-8. Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR. PMID: 24246319.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    76. Out-of-pocket fertility patient expense: data from a multicenter prospective infertility cohort. J Urol. 2014 Feb; 191(2):427-32. Wu AK, Odisho AY, Washington SL, Katz PP, Smith JF. PMID: 24018235.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    77. Benign prostate glandular tissue at radical prostatectomy surgical margins. Urology. 2013 Jul; 82(1):154-9. Odisho AY, Washington SL, Meng MV, Cowan JE, Simko JP, Carroll PR. PMID: 23522995; PMCID: PMC3696410.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    78. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int. 2012 Jul; 110(1):50-5. Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR. PMID: 22077660.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    79. Management for prostate cancer treatment related posterior urethral and bladder neck stenosis with stents. J Urol. 2011 Jan; 185(1):198-203. Erickson BA, McAninch JW, Eisenberg ML, Washington SL, Breyer BN. PMID: 21074796; PMCID: PMC3557853.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    80. A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug Des Devel Ther. 2010 Sep 07; 4:159-71. Washington SL, Shindel AW. PMID: 20856843; PMCID: PMC2939761.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    81. Prostate Cancer: Clinical Case Scenarios. Active Surveillance in African-Americans. Washington, SL III, Cooperberg, MR.
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Samuel's Networks
    Concepts (213)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (61)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.